Sun J, Gan L, Ding J, Ma R, Qian J, Xue K
Heliyon. 2023; 9(2):e13813.
PMID: 36852072
PMC: 9958441.
DOI: 10.1016/j.heliyon.2023.e13813.
Wang N, Liu R, Li J, Wang J, Xu L, Guo Q
Front Neurol. 2022; 13:1013523.
PMID: 36299272
PMC: 9588964.
DOI: 10.3389/fneur.2022.1013523.
Cho S, Kim J, Baik S, Sunwoo L, Bae Y, Choi B
Neuroradiology. 2020; 63(4):499-509.
PMID: 32865636
DOI: 10.1007/s00234-020-02538-1.
Kim U, Rathi G, Chowdhary G, Srinavasan K, Shanthi R, Krishna R
Indian J Ophthalmol. 2019; 67(12):2019-2022.
PMID: 31755442
PMC: 6896533.
DOI: 10.4103/ijo.IJO_1611_18.
Chevez-Barrios P, Eagle Jr R, Krailo M, Piao J, Albert D, Gao Y
J Clin Oncol. 2019; 37(31):2883-2891.
PMID: 31539297
PMC: 6823888.
DOI: 10.1200/JCO.18.01808.
Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas.
Lopez J, Fernandez Alonso N, Cuevas Alvarez J, Garcia-Caballero T, Pastor Jimeno J
Clin Ophthalmol. 2018; 12:1171-1179.
PMID: 29988700
PMC: 6029607.
DOI: 10.2147/OPTH.S141503.
Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion?.
Berry J, Zolfaghari E, Chen A, Murphree A, Jubran R, Kim J
Ocul Oncol Pathol. 2018; 3(4):283-291.
PMID: 29344482
PMC: 5757559.
DOI: 10.1159/000464468.
Blood flow velocity in monocular retinoblastoma assessed by color Doppler.
Bonanomi M, Saito O, Lima P, Bonanomi R, Chammas M
Clinics (Sao Paulo). 2016; 70(12):797-803.
PMID: 26735219
PMC: 4676317.
DOI: 10.6061/clinics/2015(12)06.
Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan R, Qaddoumi I, Billups C, Free T, Haik B, Rodriguez-Galindo C
Br J Ophthalmol. 2015; 99(10):1366-71.
PMID: 25873648
PMC: 5148135.
DOI: 10.1136/bjophthalmol-2014-306364.
Management of retinoblastoma in children: current status.
Chantada G, Schaiquevich P
Paediatr Drugs. 2015; 17(3):185-98.
PMID: 25742925
DOI: 10.1007/s40272-015-0121-9.
Innovative ophthalmology.
Natarajan S
Indian J Ophthalmol. 2014; 62(11):1043-1044.
PMID: 25494243
PMC: 4290191.
DOI: 10.4103/0301-4738.146706.
Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation.
Brisse H, de Graaf P, Galluzzi P, Cosker K, Maeder P, Goricke S
Eur Radiol. 2014; 25(5):1443-52.
PMID: 25433413
DOI: 10.1007/s00330-014-3514-1.
Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.
Grossniklaus H
Am J Ophthalmol. 2014; 158(5):875-91.
PMID: 25065496
PMC: 4250440.
DOI: 10.1016/j.ajo.2014.07.025.
Establishment of the relationship between tumor size and range of histological involvement to evaluate the rationality of current retinoblastoma management.
Yan J, Zhang H, Li Y
PLoS One. 2013; 8(11):e80484.
PMID: 24312226
PMC: 3842917.
DOI: 10.1371/journal.pone.0080484.
Orbital retinoblastoma: Present status and future challenges - A review.
Ali M, Honavar S, Reddy V
Saudi J Ophthalmol. 2013; 25(2):159-67.
PMID: 23960917
PMC: 3729383.
DOI: 10.1016/j.sjopt.2010.10.010.
Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma.
Graeber C, Gobin Y, Marr B, Dunkel I, Brodie S, Bornfeld N
Open Ophthalmol J. 2011; 5:1-5.
PMID: 21399766
PMC: 3052645.
DOI: 10.2174/1874364101105010001.
Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments.
Balaguer J, Wilson M, Billups C, Mancini J, Haik B, Qaddoumi I
Pediatr Blood Cancer. 2008; 52(3):351-6.
PMID: 19021223
PMC: 4643656.
DOI: 10.1002/pbc.21845.
Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison.
Brisse H, Guesmi M, Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L
Pediatr Radiol. 2007; 37(7):649-56.
PMID: 17479257
DOI: 10.1007/s00247-007-0491-4.
Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?.
Chantada G, Dunkel I, de Davila M, Abramson D
Br J Ophthalmol. 2004; 88(8):1069-73.
PMID: 15258027
PMC: 1772257.
DOI: 10.1136/bjo.2003.037044.
Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.
Marback E, Arias V, Paranhos Jr A, Soares F, Murphree A, Erwenne C
Br J Ophthalmol. 2003; 87(10):1224-8.
PMID: 14507753
PMC: 1920792.
DOI: 10.1136/bjo.87.10.1224.